Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis
2
x
$
30.00
Psychopharmacology Bulletin VOL 46 No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Patricia K. Corey-Lisle, PhD, RN,CS-P: Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study
1
x
$
30.00
OPEN ACCESS: Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future
1
x
$
0.00
VOL 3 No. 10 Full Issue - October 2001
1
x
$
20.00
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)
1
x
$
30.00
Sistemas de Diagnostico y Classificacion
1
x
$
0.00
Nienke Dekker, MD: Cessation of Cannabis Use by Patients with Recent-Onset Schizophrenia and Related Disorders
1
x
$
30.00
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
1
x
$
30.00
Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence
2
x
$
30.00
P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor
1
x
$
30.00
View Cart
Checkout
Home
Store
“P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Anxiety Disorders: Vast Progress but a Long Journey Ahead
$
0.00
Add to cart
Details
Psychiatric Bulletin: Late-Breaking Clinical News
$
0.00
Add to cart
Details
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Establishing a ‘Gateway’ for Patients with Anxiety
$
0.00
Add to cart
Details
Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
$
30.00
Add to cart
Details
The Effect of Food on the Absorption of Oral Ziprasidone
$
30.00
Add to cart
Details
Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Innovative Treatment Strategies With Anticonvulsants: A Focus on Bipolar Disorder
$
10.00
Add to cart
Details
Generalized Anxiety Disorder – A Doctor’s Guide
$
15.00
Add to cart
Details
Atypical Anti psychotic Drugs – A Doctor’s Guide
$
15.00
Add to cart
Details
Depression Rating Scales – A Doctor’s Guide
$
15.00
Add to cart
Details
Amisulpride for Clozapine Induced Sialorrhea
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
$
30.00
Add to cart
Details
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Antipsychotic Treatment of Autistic Shutdowns—A Case Study
$
30.00
Add to cart
Details
Akinetic Mutism Following Bilateral Infarcts Associated with a Mitral Valve Papillary Fibroelastoma
$
30.00
Add to cart
Details
Kuwait-Mental Illness Disability Scale (K-MIDS): A Proposal
$
30.00
Add to cart
Details
Previous
1
…
23
24
25
…
44
Next
Page load link
Go to Top
